DDI’s Research at ENDO 2026

Published on

We are proud of Dasman Diabetes Institute’s participation in ENDO 2026, the annual meeting of the Endocrine Society and one of the world’s leading scientific conferences in endocrinology and diabetes.

This participation reflects the Institute’s commitment to advancing scientific research, strengthening its international presence, and contributing to the development of knowledge that improves health outcomes.